S. Yılmaz Et Al. , " An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?," Anadolu Kliniği Tıp Bilimleri Dergisi , vol.25, no.1, pp.79-84, 2020
Yılmaz, S. Et Al. 2020. An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?. Anadolu Kliniği Tıp Bilimleri Dergisi , vol.25, no.1 , 79-84.
Yılmaz, S., Elaldı, N., & Ertin, H., (2020). An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?. Anadolu Kliniği Tıp Bilimleri Dergisi , vol.25, no.1, 79-84.
Yılmaz, Sarper, Nazif Elaldı, And Hakan ERTİN. " An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?," Anadolu Kliniği Tıp Bilimleri Dergisi , vol.25, no.1, 79-84, 2020
Yılmaz, Sarper Et Al. " An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?." Anadolu Kliniği Tıp Bilimleri Dergisi , vol.25, no.1, pp.79-84, 2020
Yılmaz, S. Elaldı, N. And Ertin, H. (2020) . " An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?." Anadolu Kliniği Tıp Bilimleri Dergisi , vol.25, no.1, pp.79-84.
@article{article, author={Sarper Yılmaz Et Al. }, title={ An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?}, journal={Anadolu Kliniği Tıp Bilimleri Dergisi}, year=2020, pages={79-84} }